Guselkumab in the treatment of severe hidradenitis suppurativa, a promising role?

Dermatol Ther. 2021 May;34(3):e14930. doi: 10.1111/dth.14930. Epub 2021 Mar 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Hidradenitis Suppurativa* / diagnosis
  • Hidradenitis Suppurativa* / drug therapy
  • Humans

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • guselkumab